Global Medical REIT Inc. (GMRE)
NYSE: GMRE · Real-Time Price · USD
7.86
+0.12 (1.55%)
Dec 20, 2024, 4:00 PM EST - Market closed
Global Medical REIT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Rental Revenue | 136.39 | 140.93 | 137.17 | 115.8 | 93.52 | 70.52 | Upgrade
|
| Other Revenue | 0.2 | 0.12 | 0.12 | 0.13 | 0.21 | 0.21 | Upgrade
|
| Total Revenue | 136.59 | 141.05 | 137.28 | 115.94 | 93.73 | 70.73 | Upgrade
|
| Revenue Growth (YoY | -5.41% | 2.74% | 18.41% | 23.69% | 32.53% | 32.96% | Upgrade
|
| Property Expenses | - | 0.04 | 0.35 | 0.15 | 6.3 | 6.54 | Upgrade
|
| Selling, General & Administrative | 50.46 | 50.01 | 46.68 | 35.86 | 25.63 | 14.25 | Upgrade
|
| Depreciation & Amortization | 40.44 | 41.27 | 40.01 | 33.83 | 26.75 | 19.07 | Upgrade
|
| Total Operating Expenses | 101.75 | 103.11 | 98.81 | 78.97 | 65.46 | 43.67 | Upgrade
|
| Operating Income | 34.84 | 37.94 | 38.47 | 36.97 | 28.28 | 27.06 | Upgrade
|
| Interest Expense | -28.1 | -30.89 | -25.23 | -19.7 | -18.68 | -17.47 | Upgrade
|
| EBT Excluding Unusual Items | 6.73 | 7.04 | 13.24 | 17.27 | 9.6 | 9.59 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.56 | 15.56 | 6.75 | 1.07 | - | - | Upgrade
|
| Other Unusual Items | -0.87 | -0.87 | - | - | -12.09 | - | Upgrade
|
| Pretax Income | 4.3 | 21.73 | 20 | 18.34 | -2.5 | 9.59 | Upgrade
|
| Earnings From Continuing Operations | 4.3 | 21.73 | 20 | 18.34 | -2.5 | 9.59 | Upgrade
|
| Minority Interest in Earnings | 0.12 | -1.12 | -0.85 | -0.72 | 0.57 | -0.35 | Upgrade
|
| Net Income | 4.42 | 20.61 | 19.14 | 17.62 | -1.93 | 9.23 | Upgrade
|
| Preferred Dividends & Other Adjustments | 5.82 | 5.82 | 5.82 | 5.82 | 5.82 | 5.82 | Upgrade
|
| Net Income to Common | -1.4 | 14.79 | 13.32 | 11.8 | -7.75 | 3.41 | Upgrade
|
| Net Income Growth | -79.75% | 7.68% | 8.63% | - | - | -31.55% | Upgrade
|
| Basic Shares Outstanding | 66 | 66 | 65 | 61 | 46 | 34 | Upgrade
|
| Diluted Shares Outstanding | 66 | 66 | 65 | 61 | 46 | 34 | Upgrade
|
| Shares Change (YoY) | 0.12% | 0.13% | 7.95% | 31.10% | 36.59% | 54.13% | Upgrade
|
| EPS (Basic) | -0.02 | 0.23 | 0.20 | 0.19 | -0.17 | 0.10 | Upgrade
|
| EPS (Diluted) | -0.02 | 0.23 | 0.20 | 0.19 | -0.17 | 0.10 | Upgrade
|
| EPS Growth | - | 10.89% | 4.57% | - | - | -71.13% | Upgrade
|
| Dividend Per Share | 0.840 | 0.840 | 0.840 | 0.820 | 0.800 | 0.800 | Upgrade
|
| Dividend Growth | 0% | 0% | 2.44% | 2.50% | 0% | 0% | Upgrade
|
| Operating Margin | 25.50% | 26.89% | 28.02% | 31.89% | 30.17% | 38.26% | Upgrade
|
| Profit Margin | -1.03% | 10.49% | 9.70% | 10.18% | -8.27% | 4.82% | Upgrade
|
| Free Cash Flow Margin | 49.53% | 48.52% | 55.75% | 59.49% | 36.83% | 51.50% | Upgrade
|
| EBITDA | 86.76 | 91.87 | 91.19 | 80.36 | 62.27 | 50.82 | Upgrade
|
| EBITDA Margin | 63.52% | 65.13% | 66.43% | 69.31% | 66.43% | 71.86% | Upgrade
|
| D&A For Ebitda | 51.93 | 53.93 | 52.72 | 43.39 | 33.99 | 23.76 | Upgrade
|
| EBIT | 34.84 | 37.94 | 38.47 | 36.97 | 28.28 | 27.06 | Upgrade
|
| EBIT Margin | 25.50% | 26.89% | 28.02% | 31.89% | 30.17% | 38.26% | Upgrade
|
| Funds From Operations (FFO) | 55.86 | 58.36 | 64.03 | 58.22 | 27.98 | 28.4 | Upgrade
|
| Adjusted Funds From Operations (AFFO) | - | 64.31 | 68.04 | 61.36 | 43.94 | 28.4 | Upgrade
|
| FFO Payout Ratio | 106.65% | 101.14% | 91.24% | 90.18% | 142.75% | 102.71% | Upgrade
|
| Revenue as Reported | 136.59 | 141.05 | 137.28 | 115.94 | 93.73 | 70.73 | Upgrade
|
Source: S&P Capital IQ. Real Estate template. Financial Sources.